JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB277807

Anti-LOXL2 antibody [7HCLC]

Be the first to review this product! Submit a review

|

(0 Publication)

Rabbit Recombinant Multiclonal LOXL2 antibody. Suitable for ICC, WB and reacts with Human samples. Immunogen corresponding to Synthetic Peptide within Human LOXL2.

View Alternative Names

Lysyl oxidase homolog 2, Lysyl oxidase-like protein 2, Lysyl oxidase-related protein 2, Lysyl oxidase-related protein WS9-14, LOXL2

3 Images
Immunocytochemistry - Anti-LOXL2 antibody [7HCLC] (AB277807)
  • ICC

Supplier Data

Immunocytochemistry - Anti-LOXL2 antibody [7HCLC] (AB277807)

For immunofluorescence analysis, HeLa cells were fixed and permeabilized for detection of endogenous LOXL2 using Anti-LOXL2 Recombinant Rabbit Polyclonal Antibody (ab277807, 5 μg/mL) and labeled with Goat anti-Rabbit IgG (H+L) Superclonal Secondary Antibody, Alexa Fluor® 488 conjugate (1/2000). Nuclei (blue) is stained using SlowFade® Gold Antifade Mountant with DAPI and cytoskeletal F-actin (red) staining using Rhodamine Phalloidin (1/300) Panel a-d) shows representative un-treated cells that were stained for detection and localization of LOXL2 protein (green) with less signal. Panel e-h) clearly demonstrate enhanced perinuclear localisation of LOXL2 in cells treated with Cobalt chloride (100M 16h). The images were captured at 60X magnification.

Western blot - Anti-LOXL2 antibody [7HCLC] (AB277807)
  • WB

Supplier Data

Western blot - Anti-LOXL2 antibody [7HCLC] (AB277807)

Western blot analysis was performed on whole cell extracts (30 μg lysate) of HeLa (human epithelial cell line from cervix adenocarcinoma) (Lane 1), HeLa treated with cobalt chloride (100 M for 16 hrs) (Lane 2), U-87 MG (human glioblastoma-astrocytoma epithelial cell line) (Lane 3), U-87 MG treated with cobalt chloride (100 M for 16 hrs) (Lane 4), MDA-MB-231 (human breast adenocarcinoma cell line) (Lane 5), MDA-MB-231 treated with cobalt chloride (100 M for 16 hrs) (Lane 6), A549 (human lung carcinoma cell line) (Lane 7) and A549 treated with cobalt chloride (100 M for 16 hrs) (Lane 8).

The blots were probed with Anti-LOXL2 Recombinant Rabbit Multiclonal Antibody (ab277807, 2.5 μg/mL) and detected by chemiluminescence using a Goat anti-Rabbit IgG (H+L)-HRP secondary antibody, (0.4 μg/mL, 1/4000 dilution). A 87 kDa band corresponding to LOXL2 was observed across the cell lines tested.

4-12% Bis-Tris gel.

The membrane was probed with the relevant primary and secondary antibody following blocking with 5% skimmed milk.

Chemiluminescent detection was ECL.

All lanes:

Western blot - Anti-LOXL2 antibody [7HCLC] (ab277807)

Predicted band size: 87 kDa

false

Western blot - Anti-LOXL2 antibody [7HCLC] (AB277807)
  • WB

Supplier Data

Western blot - Anti-LOXL2 antibody [7HCLC] (AB277807)

Knockdown of LOXL2 was achieved by transfecting U87MG cells with LOXL2 specific validated siRNA.

Western blot analysis was performed using modified whole cell extract (1% SDS) from the LOXL2 knock down cells (lane 3), non-specific scrambled siRNA transfected cells (lane 2) and nontransfected cells (lane 1).

The blots were probed with ab277807 at 1-3 μg/mL and a Goat anti-Rabbit IgG (H+L)-HRP secondary antibody (0.4 μg/mL, 1/2500 dilution).

Loss of signal upon siRNA mediated knock down confirms that antibody is specific to LOXL2.

All lanes:

Western blot - Anti-LOXL2 antibody [7HCLC] (ab277807)

Predicted band size: 87 kDa

false

Key facts

Host species

Rabbit

Clonality

Multiclonal

Clone number

7HCLC

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC, WB

applications

Immunogen

Synthetic Peptide within Human LOXL2. The exact immunogen used to generate this antibody is proprietary information.

Q9Y4K0

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICC" : {"fullname" : "Immunocytochemistry", "shortname":"ICC"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICC-species-checked": "testedAndGuaranteed", "ICC-species-dilution-info": "5 µg/mL", "ICC-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "2.5 µg/mL", "WB-species-notes": "<p></p>" } } }

Product details

What are recombinant multiclonals?
Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including:

  • - The sensitivity of polyclonal antibodies by recognising multiple epitopes
  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

View our range of recombinant multiclonal antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.4 Preservative: 0.09% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Mediates the post-translational oxidative deamination of lysine residues on target proteins leading to the formation of deaminated lysine (allysine) (PubMed : 27735137). Acts as a transcription corepressor and specifically mediates deamination of trimethylated 'Lys-4' of histone H3 (H3K4me3), a specific tag for epigenetic transcriptional activation (PubMed : 27735137). Shows no activity against histone H3 when it is trimethylated on 'Lys-9' (H3K9me3) or 'Lys-27' (H3K27me3) or when 'Lys-4' is monomethylated (H3K4me1) or dimethylated (H3K4me2) (PubMed : 27735137). Also mediates deamination of methylated TAF10, a member of the transcription factor IID (TFIID) complex, which induces release of TAF10 from promoters, leading to inhibition of TFIID-dependent transcription (PubMed : 25959397). LOXL2-mediated deamination of TAF10 results in transcriptional repression of genes required for embryonic stem cell pluripotency including POU5F1/OCT4, NANOG, KLF4 and SOX2 (By similarity). Involved in epithelial to mesenchymal transition (EMT) via interaction with SNAI1 and participates in repression of E-cadherin CDH1, probably by mediating deamination of histone H3 (PubMed : 16096638, PubMed : 24414204, PubMed : 27735137). During EMT, involved with SNAI1 in negatively regulating pericentromeric heterochromatin transcription (PubMed : 24239292). SNAI1 recruits LOXL2 to pericentromeric regions to oxidize histone H3 and repress transcription which leads to release of heterochromatin component CBX5/HP1A, enabling chromatin reorganization and acquisition of mesenchymal traits (PubMed : 24239292). Interacts with the endoplasmic reticulum protein HSPA5 which activates the IRE1-XBP1 pathway of the unfolded protein response, leading to expression of several transcription factors involved in EMT and subsequent EMT induction (PubMed : 28332555). Involved in E-cadherin repression following hypoxia, a hallmark of EMT believed to amplify tumor aggressiveness, suggesting that it may play a role in tumor progression (PubMed : 20026874). When secreted into the extracellular matrix, promotes cross-linking of extracellular matrix proteins by mediating oxidative deamination of peptidyl lysine residues in precursors to fibrous collagen and elastin (PubMed : 20306300). Acts as a regulator of sprouting angiogenesis, probably via collagen IV scaffolding (PubMed : 21835952). Acts as a regulator of chondrocyte differentiation, probably by regulating expression of factors that control chondrocyte differentiation (By similarity).
See full target information LOXL2

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com